Rainer Schulz had established and led an independent research group within the Department of Pathophysiology, University of Essen, Medical School, and has (since January 2011) been appointed as Chairman of Physiology at the Justus-Liebig University Giessen. His research group uses a translational approach from subcellular particles towards large animal model to define new targets involved in ischemia/reperfusion injury and investigate novel treatment strategies for protecting the heart. Professor Schulz received the Young Investigator Award from the European Society of Cardiology (ESC), the Fraenkel and Franz-Groedel Award as well as the Basic Science Lecture Award of the German Cardiac Society. Dr. Schulz served as Chairman of the Working Group on Cellular Biology of the Heart of the ESC and he is currently member of the International Council of the Society of Heart Research (ISHR) and the program committee of the German Cardiac Society. Since 2001 he has published more than 160 peer-reviewed articles and wrote 5 book chapters. His H-index is 70 with a total number of citations over 16,400. Prof. Schulz is the Associate Editor of Cardiovascular Research (from February 2011) and the British Journal of Pharmacology (since 2008) and he serves on the Editorial Board of several cardiovascular journals. He has successfully collaborated with other research teams nationally and internationally including Pharmahungary’s CEO, Prof. Peter Ferdinandy, as indicated by numerous co-authored publications.

Translational approach from subcellular particles towards large animal model to define new targets involved in ischemia/reperfusion injury and investigate novel treatment strategies for protecting the heart.